Is a complete RMD research report available?

No complete published report is available for ResMed Inc. (RMD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

RMD Stock Analysis, Forecast & Valuation

Market cap	28.2B
Revenue (ttm)	5.5B
Net income (ttm)	1.5B
EPS (ttm)	$10.4
Shares out	144.2M
P/E (trailing)	18.8x
P/E (forward)	16.4x
Dividend	$2.40 (1.23%)
Volume	1,005,229

Beta	0.78

Price target	$248	+27.0%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RMD indicators

Market & fundamental data

Available fields

284

Groups with data

Currency

USD

Showing 284 of 284 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000943819
Company name	ResMed Inc.
Country	United States
Country code	US
Cusip	761152107
Employees	9,980
Employees Change	-160%
Employees Change Percent	-1.58
Enterprise value	$27.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Instruments & Supplies
Industry PE	64.87
Industry PE Fwd	20.65
IPO Date	1995-06-02
Isin	US7611521078
Last refreshed	2026-07-27
Market cap	$28.2B
Market cap category	Large-Cap
Price	$195
Price currency	USD
Rev Per Employee	554,888.68x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	3841
Symbol	RMD
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.4%
EV Earnings	18x
EV Sales Forward	4.65x
EV/EBIT	14.45x
EV/EBITDA	12.69x
EV/FCF	15.59x
EV/Sales	4.94x
FCF yield	6.23%
Forward P/E	16.44x
P/B ratio	4.36x
P/E ratio	18.83x
P/S ratio	5.09x
PE Ratio10 Y	38.74x
PE Ratio3 Y	27.5x
PE Ratio5 Y	37.8x
PEG ratio	1.2x
PS Forward	4.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.18%
EBITDA Margin	38.93%
FCF margin	31.68%
Gross margin	62.18%
Gross Profit	$3.4B
Gross Profit Growth	15.51%
Gross Profit Growth Q	16.15%
Gross Profit Growth3 Y	14.58%
Gross Profit Growth5 Y	13.24%
Net Income	$1.5B
Net Income Growth	15.71%
Net Income Growth Q	9.23%
Net Income Growth Quarters	9%
Net Income Growth Years	4%
Net Income Growth3 Y	20.76%
Net Income Growth5 Y	27.15%
Pretax Margin	34.37%
Profit Margin	27.44%
Profit Per Employee	$152,261
Profitable Quarters	$20
Profitable Years	32
ROA	14.72
Roa5y	12.79
ROCE	25.46
ROE	25.25
Roe5y	23.02
ROIC	26.9
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.73%
Cagr15y	14.26%
Cagr1y	-27.89%
Cagr20y	12.42%
Cagr3y	-2.95%
Cagr5y	-4.72%
Div CAGR10	7.18%
Div CAGR3	10.89%
Div CAGR5	9%
EPS Growth	16.39
EPS Growth Q	10.48
EPS Growth Quarters	9
EPS Growth Years	4
EPS Growth3 Y	20.96
EPS Growth5 Y	27.08
FCF Growth	11.82%
FCF Growth Q	-6.7%
FCF Growth3 Y	60.86%
FCF Growth5 Y	18.6%
OCF Growth	14.34%
OCF Growth Q	-4.24%
OCF Growth10 Y	14.12%
OCF Growth3 Y	52.27%
OCF Growth5 Y	17.59%
Revenue Growth	10.28x
Revenue Growth Q	10.81x
Revenue Growth Quarters	20x
Revenue Growth Years	31x
Revenue Growth3 Y	11.31x
Revenue Growth5 Y	12.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.68
Assets	$8.8B
Cash	$1.7B
Current Assets	$4.1B
Current Liabilities	$1.4B
Debt	$843.2M
Debt EBITDA	$0.39
Debt Equity	$0.13
Debt FCF	$0.48
Equity	$6.5B
Liabilities	$2.3B
Long Term Assets	$4.7B
Long Term Liabilities	$941.2M
Net Cash	$817.3M
Net Cash By Market Cap	$2.9
Net Cash Growth	779.44%
Net Debt EBITDA	$-0.38
Net Debt Equity	$-0.13
Net Debt FCF	$-0.47
Tangible Book Value	$3B
Tangible Book Value Per Share	$20.85
WACC	8.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.01
Inventory Turnover	2.24
Net Working Capital	$1.3B
Quick ratio	2
Working Capital	$2.7B
Working Capital Turnover	$2.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	13.21%
Dividend Growth Years	13%
Dividend per share	$2.4
Dividend Years	15
Dividend Yield	1.23%
Ex Div Date	2026-05-14
Last Dividend	$0.6
Payout Frequency	Quarterly
Payout Ratio	23.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	231.46%
1Y total return	-27.87%
200-day SMA	233.7
3Y total return	-8.58%
50-day SMA	198.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.46%
All Time High	301.3
All Time High Change	-35.2%
All Time High Date	2021-09-09
All Time Low	0.61
All Time Low Change	31,942.99%
All Time Low Date	1995-06-07
ATR	6.24
Beta	0.78
Beta1y	0.28
Beta2y	0.56
Ch YTD	-18.93
High	197.6
High52	293.8
High52 Date	2025-08-22
High52ch	-33.54%
Low	194.2
Low52	180.3
Low52 Date	2026-06-02
Low52ch	8.32%
Ma50ch	-1.71%
Price vs 200-day SMA	-16.45%
RSI	46.17
RSI Monthly	40.07
RSI Weekly	35.14
Sharpe ratio	-1.23x
Sortino ratio	-1.41
Total Return	1.85%
Tr YTD	-18.5
Tr15y	638.89%
Tr1m	2.1%
Tr1w	-1.87%
Tr3m	-10.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	18
Analyst Count Top	6
Analyst Price Target Top	$228
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$2.88
Earnings EPS Estimate Growth	12.94
Earnings Revenue Estimate	1,462,659,264x
Earnings Revenue Estimate Growth	8.51x
Operating Income	$1.9B
Operating Income Growth	19.41
Operating Income Growth Q	18.63
Operating Income Growth3 Y	19.68
Operating Income Growth5 Y	16.44
Operating margin	34.76
Price target	$248
Price Target Change	$26.97
Price Target Change Top	$16.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	143,343,292%
Float Percent	99.38%
Net Borrowing	-10,000,000
Shares Insiders	0.52%
Shares Institutions	77.27%
Shares Out	144,239,563
Shares Qo Q	-0.44%
Shares Yo Y	-0.62%
Short Float	10.54%
Short Ratio	9.46
Short Shares	10.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.7B
Average Volume	1,427,027.4x
Bv Per Share	44.76
CAPEX	$-135.7M
Ch10y	196.2
Ch15y	510.8
Ch1m	2.1
Ch1w	-1.87
Ch1y	-28.57
Ch20y	758.9
Ch3m	-11.04
Ch3y	-11.22
Ch5y	-24.85
Ch6m	-22.63
Change	1.76%
Change From Open	0.51
Close	191.9
Days Gap	1.24
Depreciation Amortization	194,624,000
Dollar Volume	196,291,066.8
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$1.9B
EBITDA	$2.2B
EPS	$10.37
F Score	6
FCF	$1.8B
FCF EV Yield	6.41x
FCF Per Share	$12.16
Financing CF	-907,752,000
Fiscal Year End	June
Founded	1,989
Goodwill	3,043,136,000
Graham Number	102.19557
Graham Upside	-47.66
Income Tax	$383.7M
Investing CF	-295,261,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2010-08-31
Last Split Type	Forward
Last10k Filing Date	2025-08-08
Lynch Fair Value	$259
Lynch Upside	32.77
Ma150	226.2
Ma150ch	-13.66%
Ma20	201.3
Ma20ch	-3.02%
Net CF	727,802,000
Next Earnings Date	2026-08-06
Open	194.3
Optionable	Yes
P FCF Ratio	16.06
P OCF Ratio	14.9
Payment Date	2026-06-18
Position In Range	30.86
Ppne	728,574,000
Price Date	2026-07-24
Price EBITDA	$13.06
Ptbv Ratio	9.32
Relative Volume	0.7x
Revenue	5,537,789,000x
SBC By Revenue	1.84x
Share Based Comp	101,641,000
Tax By Revenue	6.93x
Tax Rate	20.16%
Tr20y	939.02%
Tr6m	-22.22%
Us State	California
Volume	1,005,229
Z Score	12.56

ResMed Inc. (RMD)

Coverage state: Market snapshot only — no published research

Generate the first RMD analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RMD

Frequently asked questions